Suchergebnisse - "Canioni, Danielle"

PubPharm (8)

1

Exophthalmos, Diplopia, and Bilateral Eyelid Edema : Symptoms of Ocular Mastocytosis

enthalten in: Optometry and vision science : official publication of the American Academy of Optometry | 2016

von Payerols, A. | Frouin, E. | Schiffmann, A. | +6

2

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities : a LYSA Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Dubois, S. | Viailly, P. | Mareschal, S. | +27

3

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy : a GELA/LYSA study

enthalten in: Blood | 2015

von Copie-Bergman, C. | Cuillière-Dartigues, P. | Baia, M. | +20

CommentIn: Blood. 2015 Nov 26;126(22):2439-40. - PMID 26612895

4

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab : analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Molina, T. | Canioni, D. | Copie-Bergman, C. | +19

5

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma

enthalten in: Leukemia & lymphoma | 2013

von Jardin, F. | Delfau-Larue, M. | Molina, T. | +18

CommentIn: Leuk Lymphoma. 2013 Sep;54(9):1857-8. - PMID 23517591

6

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B) : an open-label randomised phase 3 trial

enthalten in: Lancet (London, England) | 2011

von Récher, C. | Coiffier, B. | Haioun, C. | +104

CommentIn: Lancet. 2011 Nov 26;378(9806):1828-9. - PMID 22118432

7

Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma : analysis of PET-CT in a subset of PRIMA trial participants

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Trotman, J. | Fournier, M. | Lamy, T. | +18

8

High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2008

von Canioni, D. | Salles, G. | Mounier, N. | +8

1
[1]